Dr Fraser O'Rourke
- Honorary Clinical Fellow (Undergraduate Medical School)
email:
Fraser.ORourke@glasgow.ac.uk
University Hospital Wishaw, 50 Netherton Street, Wishaw, ML2 0DP
The University of Glasgow uses cookies for analytics. Find out more about our Privacy policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.
Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.
Clarity helps us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.
email:
Fraser.ORourke@glasgow.ac.uk
University Hospital Wishaw, 50 Netherton Street, Wishaw, ML2 0DP
Thompson, J. J., MacLeod, N., Will, S., O'Rourke, F., McGovern, J., Roxburgh, C. , Edwards, J. , Dolan, R. D. and McMillan, D. C. (2025) The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer. BMC Cancer, 25, 543. (doi: 10.1186/s12885-025-13426-3) (PMID:40133911) (PMCID:PMC11938618)
McGovern, J. et al. (2024) The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: comparison of composite ratios and cumulative scores. Cancer Medicine, 13(16), e70139. (doi: 10.1002/cam4.70139) (PMCID:PMC11335809)
Thompson, J. J., MacLeod, N., Will, S., O'Rourke, F., McGovern, J., Roxburgh, C. , Edwards, J. , Dolan, R. D. and McMillan, D. C. (2025) The prognostic value of a laboratory cachexia score (LCAS) defined by LDH, CRP and albumin in patients with advanced lung cancer. BMC Cancer, 25, 543. (doi: 10.1186/s12885-025-13426-3) (PMID:40133911) (PMCID:PMC11938618)
McGovern, J. et al. (2024) The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: comparison of composite ratios and cumulative scores. Cancer Medicine, 13(16), e70139. (doi: 10.1002/cam4.70139) (PMCID:PMC11335809)